Turn Therapeutics Inc. (TTRX)

NASDAQ: TTRX · Real-Time Price · USD

9.84

-0.27 (-2.67%)

At close: Aug 28, 2026, 4:00 PM EDT

9.83

-0.02 (-0.15%)

After-hours: Aug 28, 2026, 4:10 PM EDT

Turn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	10.29	5.08	0.87	1.18	2.1
Cash & Short-Term Investments	10.29	5.08	0.87	1.18	2.1
Cash Growth	222.53%	481.73%	-26.11%	-43.84%	-
Prepaid Expenses	0.14	0.12	0.23	0.02	0.02
Total Current Assets	10.43	5.2	1.1	1.2	2.13
Property, Plant & Equipment	0.06	0.08	0.12	0.03	0.08
Other Intangible Assets	0.91	0.92	0.82	0.77	0.7
Long-Term Deferred Charges	5.56	5.96	-	-	-
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.01
Total Assets	16.96	12.16	2.05	2.01	2.91

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	2.61	2.93	0.67	0.46	0.26
Current Portion of Leases	0.05	0.05	0.04	0.03	0.05
Current Unearned Revenue	-	-	-	-	1.42
Other Current Liabilities	6.11	3.03	-	-	-
Total Current Liabilities	8.76	6	0.71	0.49	1.72
Long-Term Leases	0.01	0.03	0.08	-	0.03
Long-Term Unearned Revenue	1.44	1.44	1.44	1.44	-
Total Liabilities	16.27	7.48	2.23	1.93	1.76

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0	0	0	0	0
Additional Paid-In Capital	29.89	28.14	19.02	17.51	18.37
Retained Earnings	-29.21	-22.39	-19.2	-17.43	-17.22
Comprehensive Income & Other	-	-1.07	-	-	-
Shareholders' Equity	0.69	4.69	-0.18	0.09	1.16
Total Liabilities & Equity	16.96	12.16	2.05	2.01	2.91

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	6.12	0.08	0.12	0.03	0.08
Net Cash (Debt)	4.17	5	0.75	1.16	2.02
Net Cash Growth	34.94%	564.72%	-34.98%	-42.76%	-
Net Cash Per Share	0.14	0.18	0.03	0.04	-
Filing Date Shares Outstanding	29.79	29.79	26.85	26.49	-
Total Common Shares Outstanding	29.79	29.45	26.85	26.49	-
Working Capital	1.66	-0.81	0.39	0.71	0.4
Book Value Per Share	0.02	0.16	-0.01	0.00	-
Tangible Book Value	-0.22	3.76	-1	-0.68	0.46
Tangible Book Value Per Share	-0.01	0.13	-0.04	-0.03	-
Machinery	-	-	-	-	0.01

SEC Filings: 10-K · 10-Q